Each one in plain English, with the numbers worked through for a shareholder.
20 Feb 2026capital raising announcement● Neutral
EUR lodged a prospectus for 9,000,000 EUROC options offered to Evolution Capital (or nominees). The text shown is mostly legal boilerplate and does not state the exercise terms or the reason; Evolution Capital took shortfall shares in the earlier offer.
15 Dec 2025capital raising announcement● Neutral
The replacement options offer closed with applications for 3,878,206 options (about 83% take-up). Directors will take the remaining 772,077 under their underwriting. This completes the small options offer opened 1 December.
1 Dec 2025capital raising announcement● Neutral
Prospectus for the replacement options offer, now only up to 4,650,283 new options at A$0.002 (about A$9,300), exercisable at A$0.08 to 31 Dec 2026. Directors fully underwrite it. Far smaller than the original 200M+ options plan.
18 Nov 2025capital raising announcement▲ Good
Only 4,650,283 EURO options went unexercised and expired on 14 November, so the underwriter takes that many shares at A$0.08 (about A$372,000). Nearly all other options were exercised, which is far fewer than the expected shortfall.
12 Nov 2025capital raising announcement▲ Good
EUR signed an underwriting deal with Evolution Capital to take up any EURO options unexercised at expiry on 14 November, for a A$1 fee. 35,078,124 options remained, worth up to A$2.8M at A$0.08. Replacement options still need AGM approval.
6 Oct 2025capital raising announcement● Neutral
EUR plans a replacement offer: one new option (A$0.002 each, A$0.08 exercise, expiring 31 Dec 2026) for each expiring EURO option held. Directors will take 41.7M and underwrite up to 25% each. Director participation needs approval at the November AGM.
19 Aug 2025capital raising announcement● Neutral
Prospectus offers options and shares to directors (44.66M EUROC options), CRML placement advisors (35M EURO options), a consultant (819,570 shares, 5M options), Odeon (5M) and Evolution (30M). These are not cash raisings; the text shows no proceeds. Formalises previously approved issues (inference).
7 May 2025capital raising announcement● Neutral
The options offer closed with acceptances for 136,263,206 new options, out of up to 223,076,970 offered, so about 86.8M were a shortfall. The underwriters, who are the directors, have been notified of the shortfall. At A$0.002 each the raised amount is small.
11 Apr 2025capital raising announcement● Neutral
EUR opened the options offer on 11 April, sending personalised forms to eligible holders. It closes 30 April 2025, extended from the earlier 14 April date. Directors will underwrite any shortfall, subject to shareholder approval at a coming general meeting.
8 Apr 2025capital raising announcement● Neutral
EUR lodged the prospectus for its replacement options offer: up to 223,076,970 options at A$0.002 (about A$446k), exercisable at A$0.10 to April 2027, underwritten by directors. It also covers 35M advisor options to CRML placement advisors. Terms match the March plan.
14 Mar 2025capital raising announcement● Neutral
EUR will offer holders of expiring EUROB options one new option per old at A$0.002, exercisable at A$0.10 to April 2027. Directors will apply for 42M and underwrite the rest. 35M advisor options go to CRML placement advisors. Shareholder approval is due in May.
7 Feb 2025capital raising announcement● NeutralMajor
CRML raised about US$22.5M at US$5.00 a share, with warrants at US$7.00, to fund Tanbreez and Wolfsberg. The price is below the US$8.50 of mid-January. EUR's 74.30% stake was valued at US$382M at US$5.75.
6 Dec 2024capital raising announcement● NeutralMajor
EUR raised A$2M from one institutional investor at A$0.0425 a share, a 17% discount to the 5-day average price. Funds go to Leinster sampling and drilling and working capital. Lead manager Evolution gets 6% plus 10M options (A$0.08, exp 14 Nov 2025).
12 June 2024capital raising announcement● Neutral
The options offer closed with applications for 114,380,771 new options (about 69% take-up) at A$0.005. Directors will take the remaining 52,341,194 options under their underwriting. This completes the offer announced in April.
23 May 2024capital raising announcement● Neutral
Closing date of the options offer extended again, to 7 June 2024. Administrative.
9 May 2024capital raising announcement● Neutral
Closing date of the options offer extended to 24 May 2024. Administrative.
26 Apr 2024capital raising announcement● Neutral
Options offer prospectus sent to eligible holders. Offer closes 10 May 2024 unless extended and would raise A$833,610 before costs, with directors underwriting any shortfall. Administrative step.
23 Apr 2024capital raising announcement● Neutral
Prospectus for the options offer: up to 166,721,965 new options at A$0.005 to raise about A$833,610, exercisable at A$0.08 by 14 November 2025. The offer is fully underwritten by the directors. Small raising and a formal document for the previously announced offer.
11 Apr 2024capital raising announcement● Neutral
EUR plans an offer to EUROA option holders of one new option per option held, at A$0.005 each, exercisable at A$0.08 until 14 November 2025. Directors would take 21.75M and underwrite the rest, subject to shareholder approval at a June 2024 meeting.
26 Oct 2023capital raising announcement▲ GoodMajor
Sizzle and Critical Metals secure a new equity facility expected to give CRML US$10M at closing, for Wolfsberg development. EUR expects more capital and an updated F-4; the merger still awaits SEC effectiveness and a Sizzle vote.
10 Nov 2022capital raising announcement● Neutral
Issues 5M shares. Likely the Wombat consideration for E47/4144 (inference, not stated in the notice). Routine compliance notice.
26 Oct 2022capital raising announcement● Neutral
Issues 44M shares, including 30M to Evolution Corporate on immediate exercise of EUROA options tied to the April 2022 A$30M placement. Routine compliance notice.
8 Aug 2022capital raising announcement● Neutral
Confirms issue of 7,232,508 shares to the underwriter on the expired A$0.05 options, completing the shortfall under the 25 July underwriting agreement. Routine issue notice.
1 Aug 2022capital raising announcement● Neutral
Issues 8.5M shares on exercise of A$0.05 options that expired 31 July 2022. Routine issue notice.
25 July 2022capital raising announcement▲ Good
Underwriting agreement with ADKSK Superfund to cover exercise of up to 15.6M A$0.05 options expiring 31 July 2022, worth up to A$779,888. The underwriter is not a related party and the fee is 0.05% of the underwritten amount.
7 July 2022capital raising announcement● Neutral
Issues 1.47M shares to directors on exercise of A$0.05 options expiring 31 July 2022. Routine issue notice with a small amount of cash.
4 July 2022capital raising announcement● Neutral
Issues 50M further A$0.18 options (expiring March 2025) approved at the general meeting: 15M to Tony Sage's company, 10M each to directors Day, Carter and Zhernov, and 5M to consultants. Adds potential dilution; no cash raised.
29 June 2022capital raising announcement● Neutral
Issues 115.4M placement options and 57.7M broker options (A$0.18, expiring 31 March 2025) after shareholder approval, plus 20M unlisted consultant options (A$0.12–0.18, expiring May 2025). Completes the option part of the April raise, with added potential dilution.
23 June 2022capital raising announcement● Neutral
Prospectus offering 173,076,972 free attaching options to April placement participants, closing 28 June 2022. It completes paperwork for the options promised with the A$30M raise and carries no new money. It adds potential dilution.
12 Apr 2022capital raising announcement● Neutral
Issues 230.8M placement shares from the A$30M raise announced 6 April, using existing placement capacity without shareholder vote, plus small option-exercise shares. Completes the share issue part of the raise; the attaching options still need approval.
